Shukra Pharmaceuticals Ltd. - Research Center
524632 SHUKRAPHAR Group (XT) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 44.80 | 10.29 | 14.54 | 5.95 | 2.78 |
| Operating profit | 5.42 | 1.43 | 4.62 | -1.73 | 0.60 |
| Interest | 0.15 | 0.16 | 0.25 | 0.04 | - |
| Gross profit | 6.15 | 1.30 | 1.82 | 0.86 | 0.84 |
| EPS (Rs) | 4.68 | 2.58 | 4.44 | 0.36 | 0.71 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.88 | 0.04 | -2.55 | 2.63 | 0.24 |
| Stock adjustment | 1.79 | -0.55 | 0.05 | -0.79 | -0.68 |
| Raw material | 6.82 | 6.06 | 6.87 | 4.21 | 0.42 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 2.72 | 2.50 | 2.73 | 2.17 | 1.49 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 28.05 | 0.85 | 0.26 | 2.09 | 0.96 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.02 | 0.87 | 0.93 | 0.74 | 0.72 |
| Taxation | - | 0.03 | 0.20 | 0.07 | - |
| Net profit / loss | 5.13 | 0.40 | 0.69 | 0.06 | 0.11 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 10.96 | 1.57 | 1.57 | 1.57 | 1.57 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 12.11 | 13.87 | 31.75 | -29.11 | 21.53 |
| GPM (%) | 13.47 | 12.64 | 15.19 | 10.01 | 27.62 |
| NPM (%) | 11.23 | 3.92 | 5.79 | 0.66 | 3.67 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis